Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥24 | ¥22 | ¥23 | ¥23 |
| % Growth | 6.5% | -2.1% | -2.3% | – |
| Cost of Goods Sold | ¥12 | ¥11 | ¥12 | ¥11 |
| Gross Profit | ¥12 | ¥11 | ¥11 | ¥12 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| R&D Expenses | ¥0 | ¥0 | ¥3 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥21 | ¥9 | ¥9 | ¥9 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | -¥3 | -¥0 |
| Operating Expenses | ¥21 | ¥9 | ¥9 | ¥9 |
| Operating Income | -¥9 | ¥2 | ¥2 | ¥2 |
| % Margin | -37.8% | 9.5% | 6.8% | 10.6% |
| Other Income/Exp. Net | ¥13 | ¥4 | ¥3 | ¥2 |
| Pre-Tax Income | ¥4 | ¥6 | ¥4 | ¥4 |
| Tax Expense | ¥0 | ¥1 | ¥1 | ¥1 |
| Net Income | ¥3 | ¥5 | ¥3 | ¥4 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS | 78.76 | 107.87 | 72.91 | 82.99 |
| % Growth | -27% | 47.9% | -12.1% | – |
| EPS Diluted | 78.76 | 107.87 | 72.91 | 82.99 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥1 | ¥1 | ¥1 | ¥1 |
| EBITDA | ¥5 | ¥3 | ¥5 | ¥6 |
| % Margin | 20.5% | 14.7% | 23% | 24.1% |